You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBIX Sale Disclosure
Onyia Jude · SEC Form 4 · Filed Jun 2, 2026
Sale
Calculated transaction value
$1.76M
Onyia Jude Chief Scientific Officer
NBIX
Transaction date
Jun 1, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 1 day later
NBIX daily price context
Close on/before transaction
$161
Jun 1, 2026
First close after public filing
$165.11
Jun 3, 2026
30-day return after filing
+5.54%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,000 shares @ $160.25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001894425-26-000012
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.69M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 1, 2026 | $932.14K |
| Neurocrine Biosciences Inc NBIX Current | Sale | Jun 1, 2026 | $1.76M |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 1, 2026 | $0 |